×

BI-MODAL HYALURONATE

  • US 20070059276A1
  • Filed: 09/07/2006
  • Published: 03/15/2007
  • Est. Priority Date: 09/07/2005
  • Status: Abandoned Application
First Claim
Patent Images

1. A formulation comprising a first fraction of a first ophthalmically acceptable compound and a second fraction of a second ophthalmically acceptable compound, wherein the first and second fractions are present in a total concentration of at least 10 mg/ml, and the first and second fractions have average molecular mass that differ by at least 4 million.

View all claims
  • 5 Assignments
Timeline View
Assignment View
    ×
    ×